뒤로
Virax Biolabs Group Ltd (VRAX) 수입
VRAX 주가 차트
VRAX 수입
Virax Biolabs Group Ltd
$0.19
-12.46%
$-0.02
오늘 기준:Apr 01, 12:29:03 GMT-4
아직 데이터 없음Earnings FAQ
VRAX의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Virax Biolabs Group Ltd VRAX의 지난 분기 매출 실적은 어땠나요?
Virax Biolabs Group Ltd의 매출 추정치는 얼마인가요?
Virax Biolabs Group Ltd의 수익 품질 점수는 얼마인가요?
Virax Biolabs Group Ltd는 언제 수익을 보고하나요?
Virax Biolabs Group Ltd의 예상 수익은 얼마인가요?
Virax Biolabs Group Ltd은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.2199
시가
$0.1928
일일 범위
$0.166 - $0.2
52주 범위
$0.152 - $1.34
거래량
6.3M
평균 거래량
4.1M
배당수익률
--
EPS(TTM)
-1.25
시가총액
$1.4M
VRAX란 무엇인가요?
Virax Biolabs Group Ltd. is a holding company, which engages in the sale, distribution, and marketing of diagnostics test kits and med-tech and personal protective equipment products for the prevention, detection, diagnosis, and risk management of viral diseases with a particular interest in the field of immunology. The firm is engaged in developing ViraxImmune with the intention of providing an immunology profiling platform that assesses each individual’s immune risk profile against global viral diseases as well as helping with the early diagnosis of post-viral syndromes associated with T cell exhaustion and chronic inflammation. Its product portfolio includes ViraxClear and ViraxVet. ViraxClear offers a range of accurate diagnostic testing kits and machines. ViraxVet offers various rapid and molecular tests for small animal veterinary diagnostics. The firm is initially focused on diseases associated with post-viral syndromes, including SARS-CoV-2, Human Papillomavirus (HPV), Malaria, Hepatitis B, and Herpes (HSV-1).